An introduction to obesity and dementia

Current Alzheimer Research

Volumn 4, Issue 2, 2007, Pages 97-101

  Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarkers; Dementia; Obesity; Prevention; Prospective studies

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; WEIGHT CONTROL;

DEMENTIA; EPIDEMIOLOGIC STUDIES; HUMANS; OBESITY; RESEARCH; RISK FACTORS; SEX FACTORS;

EID: 34147162861     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720507780362074     Document Type: Review

References (34)

1. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 44:1147-1152 (1996).
2. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163:1524-1528 (2003).
3. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62:1556-1560 (2005).
4. Rosengren A, Skoog I, Gustafson D, Wilhelmsen L. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med 165:321-326 (2005).
5. Stewart R, Masaki, K, Xue QL, Peila R, Petrovitch H, White LR, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 62:55-60 (2005).
6. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Jr., Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. Bmj 330:1360 (2005).
7. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363:1139-1146 (2004).
8. Puglielli L, Tanzi RE, Kovac DM. Alzheimer's disease: the cholesterol connection. Nat Neurosci 6:345-351 (2003).
9. Poirier J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol Med 9:94-101 (2003).
10. de la Torre JC. Vascular basis of Alzheimer's pathogenesis. Ann N Y Acad Sci 977:196-215 (2002).
11. Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JC, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 52:195-204 (2004).
12. Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 3:343-353 (2004).
13. Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol 59:1258-1263 (2002).
14. Friedland RP. Fish consumption and the risk of Alzheimer disease: is it time to make dietary recommendations? Arch Neurol 60:923-924 (2003).
15. Grant WB. Obesity and Alzheimer disease: roles of diet and genetics. Arch Intern Med 164:109-110; author reply 110 (2004).
16. Luchsinger JA, Mayeux R. Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep 6:261-266 (2004).
17. Haan MN. Nutrition, Cognitive Decline, and Aging. Serdi Publisher, Paris, France (2005).
18. Skoog I, Gustafson D. Hypertension and related factors in the etiology of Alzheimer's disease. Ann N Y Acad Sci 977:29-36 (2002).
19. Elkins JS, O'Meara ES, Longstreth WT, Jr., Carlson MC, Manolio, TA, Johnston, SC. Stroke risk factors and loss of high cognitive function. Neurology 63:793-799 (2004).
20. nd ed. (Eds: Wenger N, Collins P), Taylor & Francis Medical Books, Lancaster, pp. 37-52 (in press).
21. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174-180 (2000).
22. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327-1333 (2004).
23. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658-663 (2004).
24. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154:635-641 (2001).
25. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51:1256-1262 (2002).
26. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 63:1187-1192 (2004).
27. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210-1214 (2003).
28. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. Jama 292:2237-2242 (2004).
29. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107:391-397 (2003).
30. Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59:371-378 (2002).
31. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol 61:668-672 (2004).
32. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33:1078-1081 (2005).
33. Craft S. Insulin resistance syndrome and Alzheimer's disease: ageand obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 26 Suppl 1:65-69 (2005).
34. Porte D Jr, Baskin DG, Schwartz MW. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54:1264-1276 (2005).